1st Aug 2007 07:01
ReGen Therapeutics PLC01 August 2007 ReGen Announces Website Compliance ReGen Therapeutics Plc (the "Company") is pleased to announce that its websiteis now fully compliant with Rule 26 of the AIM Rules for Companies, published bythe London Stock Exchange plc. The Company's website can be viewed at the following address:- www.regentherapeutics.com The website also contains general information on the Company, its management,details of research and development projects and latest news on its activities. Further information: Andrew MarshallGreycoat CommunicationsTel: 020 7960 6007Mobile: 07785 297111 Percy LomaxChairman and Chief ExecutiveReGen Therapeutics PlcTel: 020 7153 4920 Imran Ahmad/Cecil JordaanHB CorporateTel: 0207 510 8600 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.L